Effects of Glucagon-Like Peptide-1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation.
Danish Iltaf SattiAlexander KariusJeffrey Shi Kai ChanNino IsakadzeRitu YadavKeva GargKonstantinos N AronisJoseph E MarineRonald BergerHugh CalkinsDavid SpraggPublished in: JACC. Clinical electrophysiology (2024)
These findings suggest that preprocedural use of GLP-1 RAs is not associated with a reduced risk of AF recurrence or associated adverse outcomes following ablation, and underscore the need for future research to determine whether these agents improve outcome in AF patients.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- left atrial appendage
- oral anticoagulants
- end stage renal disease
- direct oral anticoagulants
- ejection fraction
- heart failure
- newly diagnosed
- chronic kidney disease
- percutaneous coronary intervention
- prognostic factors
- peritoneal dialysis
- emergency department
- current status
- mitral valve
- radiofrequency ablation
- electronic health record